Halobetasol Propionate (BRYHALI)

Superpotent topical corticosteroid

Halobetasol Propionate (BRYHALI)

Forms and strengths
Form: TabletStrength: 0.01% w/w (0.1 mg halobetasol per gram)
Print

Indication

  • Used to treat corticosteroid-responsive skin conditions (dermatoses).
  • Used for the topical treatment of plaque psoriasis affecting a limited portion of the body surface area, excluding the face, scalp, palms, soles, armpits, and skin-fold areas; safety and efficacy have not been established for more extensive disease.

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.